RETRACTION article

Front. Oncol., 20 March 2024

Sec. Cancer Molecular Targets and Therapeutics

Volume 14 - 2024 | https://doi.org/10.3389/fonc.2024.1399853

Retraction: Establishment of criteria for molecular differential diagnosis of MPC and IPM

Following publication, the authors contacted the Editorial Office to request the retraction of the cited article, stating that they discovered a fault in their experimental design that rendered the conclusion unreliable. An investigation was conducted in accordance with Frontiers’ policies that confirmed this; therefore, the article has been retracted.

This retraction was approved by the Chief Editors of Oncology and the Chief Executive Editor of Frontiers. The authors agree to proceed with the retraction and sincerely regret any inconvenience this may have caused to the reviewers, editors and readers of Frontiers in Oncology.

Summary

Keywords

Non-small cell lung cancer (NSCLC), Multiple primary lung cancer (MPLC), intrapulmonary metastasis (IPM), next-generation sequencing (NGS), epidermal growth factor receptor (EGFR), Driver gene

Citation

Frontiers Editorial Office (2024) Retraction: Establishment of criteria for molecular differential diagnosis of MPC and IPM. Front. Oncol. 14:1399853. doi: 10.3389/fonc.2024.1399853

Received

12 March 2024

Accepted

12 March 2024

Published

20 March 2024

Approved by

Giuseppe Giaccone, Vice President Global Development, United States

Volume

14 - 2024

Updates

Copyright

*Correspondence: Frontiers Editorial Office,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics